Search News & Public Affairs

Huawei plans for more AI pharma tie-ups, says healthcare president

The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical ‌companies are ⁠investing in ⁠modelling tools and automated laboratories to shorten development timelines and improve ​efficiency.